HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ying Sun Selected Research

1,2- distearoyl- sn- glycero- 3- phosphoethanolamine- N- methoxy- poly(ethylene glycol 2000)

5/2021The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer.
1/2020Nanoparticle BAF312@CaP-NP Overcomes Sphingosine-1-Phosphate Receptor-1-Mediated Chemoresistance Through Inhibiting S1PR1/P-STAT3 Axis in Ovarian Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ying Sun Research Topics

Disease

288Neoplasms (Cancer)
05/2024 - 12/2002
216Nasopharyngeal Carcinoma
03/2024 - 11/2004
91Neoplasm Metastasis (Metastasis)
04/2024 - 08/2005
73Inflammation (Inflammations)
05/2024 - 03/2008
51Infections
05/2024 - 12/2002
38Fibrosis (Cirrhosis)
04/2024 - 07/2005
38Gaucher Disease (Gaucher's Disease)
06/2023 - 10/2005
30Carcinogenesis
01/2023 - 01/2010
29Breast Neoplasms (Breast Cancer)
11/2023 - 05/2009
23Takayasu Arteritis (Arteritis, Takayasu's)
12/2023 - 04/2012
19COVID-19
04/2024 - 01/2020
19Prostatic Neoplasms (Prostate Cancer)
03/2024 - 09/2006
19Hepatocellular Carcinoma (Hepatoma)
04/2023 - 07/2005
18Glioma (Gliomas)
01/2024 - 11/2012
17Type 2 Diabetes Mellitus (MODY)
12/2024 - 12/2007
17Lymphatic Metastasis
01/2023 - 07/2007
16Body Weight (Weight, Body)
01/2023 - 05/2007
14Ischemia
11/2023 - 08/2012
14Necrosis
01/2023 - 05/2006
14Adenocarcinoma
01/2023 - 09/2006
14Myocardial Infarction
01/2023 - 04/2005
13Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2024 - 03/2008
13Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2021 - 10/2005
12Hypertension (High Blood Pressure)
12/2024 - 12/2005
12Carcinoma (Carcinomatosis)
03/2024 - 05/2002
12Stomach Neoplasms (Stomach Cancer)
03/2024 - 06/2012
12Mitochondrial Diseases (Mitochondrial Disease)
01/2023 - 01/2013
12Glioblastoma (Glioblastoma Multiforme)
01/2021 - 08/2007
11Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 05/2009
11Obesity
01/2023 - 08/2004
10Atherosclerosis
12/2024 - 06/2015
10Virus Diseases (Viral Diseases)
04/2024 - 05/2002
10Lung Neoplasms (Lung Cancer)
03/2024 - 01/2012
10Human Influenza (Influenza)
03/2024 - 01/2017
10Wounds and Injuries (Trauma)
03/2024 - 05/2012
10Ovarian Neoplasms (Ovarian Cancer)
11/2023 - 03/2018
9Chronic Obstructive Pulmonary Disease (COPD)
12/2024 - 01/2015
9Cognitive Dysfunction
04/2024 - 01/2015
9Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 12/2002
9Colorectal Neoplasms (Colorectal Cancer)
01/2024 - 12/2010
9Parkinson Disease (Parkinson's Disease)
06/2023 - 06/2011
9Squamous Cell Carcinoma of Head and Neck
08/2021 - 03/2015
8Liver Neoplasms (Liver Cancer)
03/2024 - 07/2005
8Neutropenia
01/2024 - 09/2013
8Head and Neck Neoplasms (Head and Neck Cancer)
11/2023 - 03/2015
8Liver Cirrhosis (Hepatic Cirrhosis)
06/2023 - 07/2005
8Colonic Neoplasms (Colon Cancer)
05/2023 - 05/2010

Drug/Important Bio-Agent (IBA)

104Proteins (Proteins, Gene)FDA Link
04/2024 - 08/2005
78Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2005
59DNA (Deoxyribonucleic Acid)IBA
11/2023 - 08/2003
37Messenger RNA (mRNA)IBA
11/2023 - 11/2009
32CytokinesIBA
05/2024 - 02/2009
32Cisplatin (Platino)FDA LinkGeneric
11/2023 - 02/2012
26Therapeutic UsesIBA
12/2023 - 11/2009
24AcidsIBA
01/2024 - 05/2002
22Glucose (Dextrose)FDA LinkGeneric
01/2024 - 02/2008
21RNA (Ribonucleic Acid)IBA
12/2024 - 06/2003
21MicroRNAs (MicroRNA)IBA
10/2023 - 06/2012
18CollagenIBA
03/2024 - 01/2009
17EnzymesIBA
05/2024 - 05/2010
17LigandsIBA
03/2024 - 08/2005
17Peptides (Polypeptides)IBA
12/2023 - 12/2002
16VaccinesIBA
05/2024 - 05/2013
16Glucosylceramidase (Glucocerebrosidase)IBA
01/2023 - 10/2005
15Interleukin-6 (Interleukin 6)IBA
11/2023 - 04/2012
15GlucosidasesIBA
06/2023 - 07/2010
14AntigensIBA
05/2024 - 12/2002
14ErbB Receptors (EGF Receptor)IBA
06/2022 - 02/2010
14Glucosylceramides (Glucocerebrosides)IBA
10/2020 - 02/2010
13LipidsIBA
05/2024 - 05/2003
13Small Interfering RNA (siRNA)IBA
04/2024 - 01/2012
13Phosphotransferases (Kinase)IBA
02/2022 - 09/2006
12SaposinsIBA
05/2020 - 10/2005
11Polysaccharides (Glycans)IBA
03/2024 - 01/2019
11Long Noncoding RNAIBA
11/2023 - 01/2015
11Fluorouracil (Carac)FDA LinkGeneric
01/2023 - 02/2012
11CateninsIBA
12/2021 - 08/2014
11sphingosyl beta-glucosideIBA
10/2020 - 03/2010
11Atrial Natriuretic Factor (ANF)IBA
04/2012 - 11/2006
10AntioxidantsIBA
05/2024 - 10/2013
10Reactive Oxygen Species (Oxygen Radicals)IBA
01/2024 - 12/2005
10AntibodiesIBA
09/2023 - 06/2003
10Paclitaxel (Taxol)FDA LinkGeneric
01/2021 - 04/2007
10atrial natriuretic factor prohormone (31-67)IBA
08/2010 - 09/2006
9Monoclonal AntibodiesIBA
05/2024 - 01/2007
9Antiviral Agents (Antivirals)IBA
04/2024 - 01/2012
9Indicators and Reagents (Reagents)IBA
05/2023 - 05/2014
9ProgranulinsIBA
01/2022 - 09/2015
8Glutathione (Reduced Glutathione)IBA
05/2024 - 01/2018

Therapy/Procedure

133Therapeutics
05/2024 - 08/2004
91Radiotherapy
01/2024 - 03/2006
83Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
03/2024 - 04/2007
58Drug Therapy (Chemotherapy)
03/2024 - 02/2010
52Chemoradiotherapy
03/2024 - 04/2007
42Induction Chemotherapy
03/2024 - 10/2015
17Neoadjuvant Therapy
01/2022 - 01/2015
15Immunotherapy
03/2024 - 12/2002
12Aftercare (After-Treatment)
01/2023 - 05/2006
10Liver Transplantation
11/2023 - 10/2017
9Precision Medicine
01/2024 - 01/2017